Pharmacokinetic model for nalidixic acid in man. I. Kinetic pathways for hydroxynalidixic acid. - Suppr | 超能文献

Pharmacokinetic model for nalidixic acid in man. I. Kinetic pathways for hydroxynalidixic acid.

作者信息

Portmann G A, McChesney E W, Stander H, Moore W E

出版信息

J Pharm Sci. 1966 Jan;55(1):59-62. doi: 10.1002/jps.2600550113.

DOI:10.1002/jps.2600550113

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pharmacokinetic model for nalidixic acid in man. I. Kinetic pathways for hydroxynalidixic acid.

J Pharm Sci. 1966 Jan;55(1):59-62. doi: 10.1002/jps.2600550113.

2

Pharmacokinetic model for nalidixic acid in man. II. Parameters for absorption, metabolism, and elimination.

J Pharm Sci. 1966 Jan;55(1):72-8. doi: 10.1002/jps.2600550116.

3

[Placental passage of nalidixic acid (Negram) and pharmacokinetic studies in the newborn infant].[新生婴儿中萘啶酸（Negram）的胎盘转运及药代动力学研究]

Pharmazie. 1983 Sep;38(9):613-5.

4

[Nalidixic acid level during experimental acute pyelonephritis].[实验性急性肾盂肾炎期间的萘啶酸水平]

Int Z Klin Pharmakol Ther Toxikol. 1969 Apr;2(2):114-9.

5

[New investigation of the pharmacokinetics of nalidixic acid. I. Serum and urinary levels with normal renal function].[萘啶酸药代动力学的新研究。I. 肾功能正常时的血清和尿液水平]

Arzneimittelforschung. 1973 Sep;23(9):1311-3.

6

Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.人用未包衣片剂中萘啶酸的生物利用度——第一部分：与片剂溶出速率的相关性

Int J Clin Pharmacol Ther Toxicol. 1984 Apr;22(4):175-83.

7

Hydroxylation and oxidation of nalidixic acid in the turtle Pseudemys scripta elegans.秀丽锦龟中萘啶酸的羟基化和氧化作用

Vet Q. 1988 Jan;10(1):67-9. doi: 10.1080/01652176.1988.9694149.

8

Pharmacokinetic model for nalidixic acid in man. 3. Effect of repeated oral dosage.人萘啶酸的药代动力学模型。3. 重复口服给药的影响。

J Pharm Sci. 1967 May;56(5):594-9. doi: 10.1002/jps.2600560510.

9

[Studies on the pharmacokinetics of nalidixic acid in children of different ages].[不同年龄段儿童萘啶酸的药代动力学研究]

Z Kinderheilkd. 1970;109(2):124-34.

10

Partition of cinoxacin and nalidixic acid in canine vascular and extravascular compartments.西诺沙星和萘啶酸在犬类血管和血管外腔室中的分配。

J Pharm Pharmacol. 1979 Aug;31(8):567-8. doi: 10.1111/j.2042-7158.1979.tb13590.x.

引用本文的文献

1

Direct gradient reversed-phase HPLC analysis and preliminary pharmacokinetics of nalidixic acid, 7-hydroxymethylnalidixic acid, 7-carboxynalidixic acid, and their corresponding glucuronide conjugates in humans.萘啶酸、7-羟甲基萘啶酸、7-羧基萘啶酸及其相应葡萄糖醛酸缀合物在人体内的直接梯度反相高效液相色谱分析及初步药代动力学研究

Pharm World Sci. 1993 Jun 18;15(3):98-104. doi: 10.1007/BF02113937.

2

Microbiological metabolism of naphthyridines.萘啶类的微生物代谢

Appl Microbiol. 1969 Feb;17(2):237-41. doi: 10.1128/am.17.2.237-241.1969.

3

Pharmacokinetics of nalidixic acid in man: hydroxylation and glucuronidation.

Pharm Weekbl Sci. 1988 Oct 14;10(5):193-9. doi: 10.1007/BF01956870.